Question 1

What is TFDA and why is it important for medical device manufacturers?

Accepted Answer

The Taiwan Food and Drug Administration (TFDA) is Taiwan's regulatory authority responsible for pharmaceuticals and medical devices under the Ministry of Health and Welfare. TFDA enforces the Pharmaceutical Affairs Act and related regulations governing medical device safety, registration, and quality standards. All medical devices marketed in Taiwan require TFDA registration or device listing (depending on class), and foreign manufacturers must designate a Taiwan Representative. TFDA has been modernizing regulations to align with international standards while maintaining robust safety oversight.

Question 2

What are the TFDA medical device registration requirements?

Accepted Answer

Class I Devices: Device listing only (simplified process, no pre-market approval), Class II/III Devices: Full registration required with technical review. Key Requirements: Taiwan Representative designation (mandatory for foreign manufacturers), Quality System Documentation (QSD) - Taiwan's equivalent to ISO 13485, technical documentation (device description, intended use, labeling, instructions for use in Traditional Chinese), conformity certificate (CE marking, FDA approval, etc., or Taiwan GMP inspection), free sale certificate from country of origin, clinical data or performance reports (particularly for Class III). Timelines: Class I listing: 1-2 months, Class II: 3-6 months, Class III: 6-12 months (depending on device complexity and data sufficiency). Timelines vary based on completeness of application and whether additional information requests are issued.

Question 3

What is QSD (Quality System Documentation) and how is it different from ISO 13485?

Accepted Answer

QSD (Quality System Documentation) is Taiwan's quality management system requirement for medical device manufacturers, conceptually similar to ISO 13485 but with Taiwan-specific elements. QSD Options: Option 1: Submit comprehensive QSD to TFDA for review and approval (paper-based review), Option 2: Undergo TFDA GMP inspection at manufacturing site (on-site audit), Option 3: Provide valid ISO 13485 certificate plus additional Taiwan-specific documentation (most common for foreign manufacturers). Key Differences from ISO 13485: Taiwan-specific regulatory requirements must be addressed, TFDA reviews QSD as part of device registration process, QSD approval is device-specific (tied to registered products). Recommendations for Foreign Manufacturers: ISO 13485 certificate greatly facilitates QSD approval, provide certificate plus supplemental Taiwan-specific documentation, consider TFDA GMP inspection for multiple devices or long-term Taiwan strategy.

Question 4

What is a Taiwan Representative and what are their responsibilities?

Accepted Answer

A Taiwan Representative (also called Authorized Representative or Local Agent) is a person or legal entity established in Taiwan designated by a foreign manufacturer to act as their local regulatory representative with TFDA. Requirements: Must be domiciled in Taiwan with valid business registration, registered with TFDA for the specific manufacturer and device(s), Responsibilities: Submit device registration or listing applications to TFDA, maintain technical documentation, QSD, and certificates, serve as liaison between foreign manufacturer and TFDA, handle post-market surveillance and adverse event reporting, coordinate product recalls and corrective actions, ensure compliance with Taiwan labeling and language requirements. A Taiwan Representative is mandatory for all foreign manufacturers seeking to market devices in Taiwan. Many manufacturers engage Taiwan-based regulatory consulting firms or distributors as their representatives.

Question 5

How does Taiwan classify medical devices?

Accepted Answer

Taiwan uses a risk-based classification system aligned with international frameworks: Class I: Low risk (e.g., non-invasive devices, simple surgical instruments), listing only, no pre-market approval, Class II: Medium risk (e.g., short-term invasive, some active devices), full registration with technical review, Class III: High risk (e.g., implantable, life-sustaining, long-term invasive), most stringent registration requirements, clinical data often required. Classification is based on: invasiveness, duration of body contact, whether device is active, intended purpose and critical therapeutic nature, interaction with circulatory system or central nervous system. Higher class devices face longer review timelines and more extensive technical documentation requirements.

Question 6

What conformity certificates does TFDA accept?

Accepted Answer

TFDA accepts various international conformity certificates to support device registration applications. Accepted Certificates: CE marking (EU Notified Body certificate), FDA 510(k) clearance or PMA approval, TGA (Australia) approval, Health Canada license, Japan PMDA approval, other recognized regulatory approvals. Benefits of International Certificates: Streamlines TFDA technical review, demonstrates international acceptance and safety, may reduce clinical data requirements, can expedite approval timelines. Quality Certificates: ISO 13485 strongly preferred for QSD approval, FDA establishment registration, other internationally recognized QMS certificates. Note: International certificates support but do not replace TFDA registration - Taiwan-specific application still required with Taiwan Representative and Traditional Chinese labeling.

Question 7

How often is Taiwan TFDA regulatory news updated and how can I stay informed?

Accepted Answer

TFDA regularly publishes announcements, guidance documents, and regulatory updates related to device registration, QSD requirements, and post-market obligations. Recent focus includes digitalization of the registration system, enhanced post-market surveillance, and alignment with international standards. Our platform aggregates daily updates from 7 premium commercial sources including RAPS, Emergo by UL, Asia Actual, and Citeline. We recommend checking this page regularly and working closely with your Taiwan Representative to monitor TFDA announcements and procedural changes.

Question 8

What commercial sources does this platform use for Taiwan news?

Accepted Answer

We aggregate Taiwan regulatory intelligence from 7 premium sources: RAPS (Regulatory Affairs Professionals Society), Emergo by UL, Citeline MedTech Insight, Pacific Bridge Medical, Asia Actual, Pure Global's proprietary research, and Qualtechs. These sources provide expert analysis, real-time updates, and strategic insights beyond basic TFDA announcements, helping you navigate device registration, QSD approval, Taiwan Representative selection, and Traditional Chinese labeling requirements.

Taiwan TFDA Medical Device News 2025: Registration & Regulatory Updates | Pure Global

About Taiwan TFDA Regulatory News

Frequently Asked Questions About TFDA News